Stocks · Healthcare · Medical - Devices
RxSight, Inc. RXST
$4.68 -1.47% Close, Oct 2, 2026 · NASDAQ · Market cap $193.7M
Weak trend
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -43.2% from -27.1% a year earlier.
- The stock is 64% below its highest close of the past year.
- Over the past year the stock returned -48.1%, behind the S&P 500 by 63.1 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 16%
- Revenue growth, 3-year CAGRTop 17%
- Revenue growth accelerationTop 39%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 50%
- Gross marginTop 34%
- Operating marginBottom 36%
- Accruals (lower is better)Top 48%
- Interest coverBottom 3%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 29%
- Free-cash-flow yieldBottom 31%
- EBITDA / enterprise valueBottom 27%
- Sales / enterprise valueTop 17%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 21%
- 6-month returnBottom 17%
- 1-year return vs S&P 500Bottom 11%
- Distance from 52-week highBottom 12%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 34%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 2%
- Upside to consensus price targetBottom 47%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 45%
- Maximum drawdown, 3 yearsBottom 9%
- Beta vs S&P 500 (lower is better)Bottom 43%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -19.5% | -18.8% | ↑ |
| Gross margin | 68.4% | 77.5% | ↑ |
| Operating margin | -27.1% | -43.2% | ↓ |
| FCF margin | -13.2% | -21.3% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -18.8% | -19.5% | ↑ | Bottom 16% |
| Gross margin | 77.5% | 68.4% | ↑ | Top 34% |
| Operating margin | -43.2% | -27.1% | ↓ | Bottom 36% |
| Net margin | -36.8% | -20.5% | ↓ | — |
| Free-cash-flow margin | -21.3% | -13.2% | ↓ | — |
| Return on invested capital | -20.1% | — | Top 50% | |
| Revenue growth, 3-year CAGR | 40.0% | — | Top 17% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -6.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 24.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +198.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -3674.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -1.03%
- Shareholder yield
- -1.03%
- Share count change, 1 year
- +1.8%
- Share count change, 3-year CAGR
- +6.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +12.1%
- Average 2-day reaction, last 8
- -1.5%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $7.31
- Target vs current price
- +56.2%
- Analysts with a rating
- 12
- Share rating Buy or Strong Buy
- 25%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +12.0% | +0.6% | +12.6% | +11.8% | — |
| May 6, 2026 | -27.1% | -6.6% | -24.0% | -34.0% | -17.2% |
| Feb 25, 2026 | +34.3% | -1.5% | -14.8% | -30.0% | -31.1% |
| Nov 5, 2025 | +29.4% | -7.3% | +13.7% | +31.8% | -1.9% |
| Aug 7, 2025 | -14.1% | +3.2% | +10.1% | +12.2% | +13.8% |
| May 7, 2025 | +7.7% | +6.8% | -5.4% | +9.4% | -44.1% |
| Feb 25, 2025 | +9.6% | -0.3% | -8.1% | -14.9% | -43.3% |
| Nov 7, 2024 | +36.0% | -7.1% | -18.4% | -22.7% | -37.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.29 | -$0.33 | +12.0% | $33.7M |
| May 6, 2026 | -$0.38 | -$0.30 | -27.1% | $30.9M |
| Feb 25, 2026 | -$0.22 | -$0.33 | +34.3% | $32.6M |
| Nov 5, 2025 | -$0.24 | -$0.34 | +29.4% | $30.3M |
| Aug 7, 2025 | -$0.29 | -$0.25 | -14.1% | $33.6M |
| May 7, 2025 | -$0.20 | -$0.22 | +7.7% | $37.9M |
| Feb 25, 2025 | -$0.15 | -$0.17 | +9.6% | $40.2M |
| Nov 7, 2024 | -$0.16 | -$0.25 | +36.0% | $45.4M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 1.50× | — | — | Top 17% |
| Free-cash-flow yield | -14.02% | — | — | Bottom 31% |
| Earnings yield | -24.15% | — | — | Bottom 29% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +0.4%
- 200-day average slope (20 days)
- -8.0%
- Distance from 50-day average
- -21.9%
- Distance from 200-day average
- -32.8%
- RSI (14)
- 30.3
- Relative volume
- 0.78×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 58.6%
- Volatility vs own 5-year history
- 42th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.24
- Correlation with S&P 500
- 0.27
- Current drawdown from 1-year high
- -64.2%
- Maximum drawdown, 3 years
- -92.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| May 15, 2024 | Jun 17, 2026 | -92.9% | 523 days | Not yet recovered |
| Aug 2, 2021 | Jan 7, 2022 | -48.2% | 111 days | 316 days (Apr 13, 2023) |
| Jul 31, 2023 | Oct 30, 2023 | -37.3% | 64 days | 26 days (Dec 6, 2023) |
| Feb 27, 2024 | Mar 14, 2024 | -20.2% | 12 days | 34 days (May 2, 2024) |
| Dec 27, 2023 | Jan 3, 2024 | -13.2% | 4 days | 3 days (Jan 8, 2024) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $193.7M
- EPS, diluted (TTM)
- -$1.13
- Revenue (TTM)
- $127.6M
- 52-week range
- $4.48 – $13.22
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $22.6M | $49.0M | $89.1M | $139.9M | $134.5M |
| Gross profit | $4.5M | $21.3M | $53.8M | $98.9M | $103.0M |
| Operating income | -$52.8M | -$63.3M | -$50.1M | -$36.9M | -$48.2M |
| Net income | -$48.7M | -$66.8M | -$48.6M | -$27.5M | -$38.9M |
| EPS (diluted) | -$1.78 | -$2.41 | -$1.41 | -$0.71 | -$0.95 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $45.4M | $40.2M | $37.9M | $33.6M | $30.3M | $32.6M | $30.9M | $33.7M |
| Net income | -$6.3M | -$5.9M | -$8.2M | -$11.8M | -$9.8M | -$9.2M | -$15.9M | -$12.1M |
| EPS (diluted) | -$0.16 | -$0.15 | -$0.20 | -$0.29 | -$0.24 | -$0.22 | -$0.38 | -$0.29 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$44.7M | -$58.9M | -$41.6M | -$16.9M | -$15.5M |
| Capital expenditure | -$1.9M | -$2.4M | -$4.8M | -$5.4M | -$3.8M |
| Free cash flow | -$46.6M | -$61.2M | -$46.4M | -$22.4M | -$19.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $121.1M | $7.8M | $106.0M | $128.9M | $4.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $208.8M
- Total assets
- $352.7M
- Total liabilities
- $89.4M
- Total debt
- $10.6M
- Net debt
- -$2.8M
- Shareholders’ equity
- $263.3M
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 3,975,689
- Days to cover
- 5.52
- Change vs previous report
- +2.6%
FINRA short interest, settlement date Sep 15, 2026.